You searched for "prevention"
Speech mapping and the benefits of using in clinical practice
Fitting hearing aids is not simply a case of one size fits all. Nicole da Rocha discusses the benefits of using speech mapping as a verification tool. The verification of hearing aids has become quintessential for best practice. Using either...Unravelling the mystery of hyperacusis with pain
When a person says that sound causes them pain, how can we understand this, and determine what processes are involved? Bryan Pollard navigates us through what is presently known. Pain has long been underrepresented – and often, completely overlooked –...Tonsillectomy in adolescents
Tonsillectomy is one of the most common operations performed across the developed world. Salil Sood and Ray Clarke discuss the special considerations that apply when performing this procedure on adolescent patients. Tonsillitis in teenagers can be exceptionally painful and disruptive....User perspectives of online audiological rehabilitation programmes
Recent research shows that online audiological rehabilitation programmes have the potential to improve the quality of life of hearing aid users. However, there are still areas that need need improvement. Elisabet Thorén discusses some of the problems people face when...In conversation with Ad Snik
Professor Ad Snik has spent a large portion of his career in hearing implantation and has seen novel devices come and go, some of great benefit to patients, others which haven’t produced expected results. In this interview, he talks to...
A new era in the treatment of recalcitrant nasal polyps?
Chronic rhinosinusitis with nasal polyps (CRSwNP) can be difficult to treat effectively in patients with aggressive or recalcitrant disease. Omalizumab (Xolair) is a monoclonal anti-IgE antibody with proven benefits for patients with moderate/severe asthma and CRSwNP, but this study looks...
When to operate on a patient without chronic disease?
As ENT surgeons, we spend a lot of time managing chronic rhinosinusitis, so a review and update on the management of the acute disease is always helpful. The standard medical treatment of antibiotics, nasal steroids and nasal decongestants are reported...
Can we predict how much benefit patients will get from ESS with a novel monoclonal antibody
Mepolizumab (Nucala) is a humanised IgG1 monoclonal antibody that acts as an IL-5 antagonist. It has been shown to be highly effective in treating severe asthma. It is hypothesised that it will be effective for patients with recalcitrant CRSwNP. This...
Does minimally invasive surgery under local anaesthesia have a role in the management of chronic rhinusinusitis?
A formal FESS procedure usually done under local anaesthesia is considered as gold standard in the management of chronic rhinusinusitis. However, success is hampered by a significant recurrence rate of polyps requiring revision surgery, long waiting lists, reluctance of elderly...
The septum and breathing
The authors compared the improvement in nasal obstructive symptoms in two groups of patients. One group underwent septoplasty alone and the other septoplasty accompanied with compensatory turbinoplasty. They used the Nasal Obstruction Symptom Evaluation (NOSE) [12] and visual analog scale...
Sinus implants to treat recalcitrant polyps
It is well established that the burden of chronic rhinosinusitis on healthcare costs and patients’ quality of life is high, and that current mainstream treatment options of oral or topical steroids are not without problems. This paper compares two RCTSs...
